Clinical Trial Update: Iguratimod as Treatment for Refractory Lupus Nephritis [NA]

View source ↗

Summary

This document notes a clinical trial evaluating iguratimod for refractory lupus nephritis, sponsored by RenJi Hospital; phase and status are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: RenJi Hospital | Conditions: Lupus Nephritis | NA | Status: UNKNOWN